Substance
CLARITHROMYCIN
Global reference: every product and company linked to this substance.
- cas: 81103-11-9
- ncit: C1054
- pubchem_cid: 84029
- rxnorm: 21212
- unii: H1250JIK0A
A-56268 · ABBOTT-56268 · BIAXIN · clarithromycin [INN] · CLARITHROMYCIN [JAN] · Clarithromycin [WHO-DD] · CLAROSIP · CYLLIND · KLACID · KLARICID · MACLADIN · MAVID
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC. COMMON STOCK | OMECLAMOX-PAK | Q3 2025 | $0.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (7)
- BIAXIN · ABBVIE INC. COMMON STOCK
- BIAXIN XL · ABBVIE INC. COMMON STOCK
- CLARITHROMYCIN · ANI PHARMACEUTICALS INC.
- LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) · ANI PHARMACEUTICALS INC.
- OMECLAMOX-PAK · CUMBERLAND PHARMACEUTICALS INC. COMMON STOCK
- PREVPAC (COPACKAGED) · TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- VOQUEZNA TRIPLE PAK · PHATHOM PHARMACEUTICALS INC. COMMON STOCK
Companies holding this asset (7)
- ANI PHARMACEUTICALS INC.
- ABBVIE INC. COMMON STOCK
- CUMBERLAND PHARMACEUTICALS INC. COMMON STOCK
- DR. REDDY'S LABORATORIES LTD COMMON STOCK
- PHATHOM PHARMACEUTICALS INC. COMMON STOCK
- TAKEDA PHARMACEUTICAL COMPANY LIMITED AMERICAN DEPOSITARY SHARES (EACH REPRESENTING 1/2 OF A SHARE OF COMMON STOCK)
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES